11:06 AM EDT, 04/25/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending modestly higher Thursday morning, rising 0.24% to 1,364.10 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by consumer goods company Unilever (UL) and pharmaceutical company Sanofi (SNY), which rose 5.5% and 5.4% respectively. They were followed by biopharmaceutical company Cellectis (CLLS) and medical device maker EDAP TMS (EDAP), which increased 0.4% and 4.7% respectively.

The decliners from continental Europe were led by biotech firm Biophytis (BPTS) and internet browser company Opera (OPRA), which fell 6.4% and 5.9% respectively. They were followed by pharmaceutical company Ascendis Pharma (ASND) and biopharmaceutical company Calliditas Therapeutics (CALT), which dropped 3.1% and 3.3% respectively.

From the UK and Ireland, the gainers were led by financial services company Barclays (BCS) and biopharmaceutical company TC Biopharm (TCBP), which rose 8% and 7.5% respectively. They were followed by pharmaceutical company AstraZeneca (AZN) and biotech firm Trinity Biotech (TRIB), which were up 6% and 4.9% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies NuCana (NCNA) and Biodexa Pharmaceuticals (BDRX), which lost 2.1% and 6.8% respectively. They were followed by pharmaceutical company Avadel Pharmaceuticals (AVDL) and biotech firm Autolus Therapeutics (AUTL), which were down 2.5% and 3.2% respectively.

http://www.mtnewswires.com
Copyright © 2024 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.